osurnia
dechra regulatory b.v. - betamethasone acetate, terbinafine, florfenicol - krefur og antiinfectives í samsetning - hundar - meðferð við bráðri utanbólgu.
mirataz
dechra regulatory b.v. - mírtasapín - psychoanaleptics, antidepressants in combination with psycholeptics - kettir - fyrir líkamsþyngd ná í ketti að upplifa léleg matarlyst og þyngd tap sem leiðir af langvarandi sjúkdóma.
canaural (fucidin comp. vet.) eyrnadropar, dreifa
dechra veterinary products a/s* - framycetinum súlfat; diaethanolaminum fusidas; nystatinum inn; prednisolonum inn - eyrnadropar, dreifa
malaseb vet. hársápa 2 % w/v
dechra veterinary products a/s* - chlorhexidinum díglúkónat; miconazolum nítrat - hársápa - 2 % w/v
metrobactin vet tafla 250 mg
dechra regulatory b.v. - metronidazolum inn - tafla - 250 mg
phenoleptil tafla 100 mg
dechra regulatory b.v. - phenobarbitalum inn - tafla - 100 mg
phenoleptil tafla 25 mg
dechra regulatory b.v. - phenobarbitalum inn - tafla - 25 mg
spectrabactin vet tafla 200 mg/50 mg
dechra regulatory b.v. - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 200 mg/50 mg
spectrabactin vet tafla 40 mg/10 mg
dechra regulatory b.v. - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 40 mg/10 mg
spevigo
boehringer ingelheim international gmbh - spesolimab - psoriasis - Ónæmisbælandi lyf - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.